Advertisement
Screener

Evome Medical Technologies, Inc. Financing Cash Flow

Evome Medical Technologies, Inc. Financing Cash Flow

Evome Medical Technologies, Inc. reported Financing Cash Flow of CAD 824.54 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2024-04-16

  • Evome Medical Technologies, Inc. net cash provided by (used in) financing activities for the quarter ending 2023-12-31 was -1.54M CAD, a 733.46% decline year-over-year.
  • Evome Medical Technologies, Inc. net cash provided by (used in) financing activities for the quarter ending 2023-09-30 was 19.67K CAD, a 99.16% decline year-over-year.
  • Evome Medical Technologies, Inc. net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was -229.88K CAD.
  • Evome Medical Technologies, Inc. net cash provided by (used in) financing activities for the quarter ending 2023-03-31 was 2.58M CAD, a 43.37% decline year-over-year.
  • Evome Medical Technologies, Inc. net cash provided by (used in) financing activities for fiscal 2023 was 824.54K CAD.
  • Evome Medical Technologies, Inc. net cash provided by (used in) financing activities for fiscal 2022 was 3.94M CAD, a 27.54% decline from fiscal 2021.
  • Evome Medical Technologies, Inc. net cash provided by (used in) financing activities for fiscal 2021 was 5.43M CAD.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 10 monthNet Cash Provided by (Used in) Financing Activities 10 month as first filedNet Cash Provided by (Used in) Financing Activities 12 month
2023-12-31-1.54M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
-1.52M CAD
derived: sum of 2 quarters · filed 2024-04-16
-1.75M CAD
derived: sum of 3 quarters · filed 2024-04-16
824.54K CAD
10-K · filed 2024-04-16
2023-09-3019.67K CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-210.20K CAD
derived: sum of 2 quarters · filed 2023-11-14
2.37M CAD
10-Q · filed 2023-11-14
2023-06-30-229.88K CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
2.35M CAD
10-Q · filed 2023-08-14
2023-03-312.58M CAD
10-Q · filed 2023-05-15
2022-12-31388.09K CAD
10-K · filed 2024-04-16
-220.16K CAD
10-KT · filed 2023-04-03
2022-11-30243.55K CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-17
560.71K CAD
10-Q · filed 2023-01-17
2022-09-302.35M CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
6.05M CAD
10-Q · filed 2023-11-14
2022-08-31509.90K CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-17
317.15K CAD
10-Q · filed 2022-10-17
2022-06-30-855.79K CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
3.70M CAD
10-Q · filed 2023-08-14
2022-05-31-192.75K CAD
10-Q · filed 2022-07-15
2022-03-314.55M CAD
10-Q · filed 2023-05-15
2022-02-285.03M CAD
derived: 10-KT 12 month − 10-Q 9 month · filed 2023-04-03
4.83M CAD
derived: sum of 2 quarters · filed 2023-04-03
4.28M CAD
derived: sum of 3 quarters · filed 2023-04-03
3.94M CAD
10-KT · filed 2023-04-03
2021-12-31-658.70K CAD
10-KT · filed 2023-04-03
2021-11-30-200.33K CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-17
-745.12K CAD
derived: sum of 2 quarters · filed 2023-01-17
-1.09M CAD
10-Q · filed 2023-01-17
4.33M CAD
derived: sum of 4 quarters · filed 2023-01-17
2021-08-31-544.79K CAD
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-17
-891.73K CAD
10-Q · filed 2022-10-17
4.53M CAD
derived: sum of 3 quarters · filed 2022-10-17
4.54M CAD
derived: sum of 4 quarters · filed 2022-10-17
2021-05-31-346.94K CAD
10-Q · filed 2022-07-15
5.08M CAD
derived: sum of 2 quarters · filed 2022-07-15
5.08M CAD
derived: sum of 3 quarters · filed 2022-07-15
2021-02-285.43M CAD
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31
5.43M CAD
derived: sum of 2 quarters · filed 2022-05-31
5.43M CAD
10-K · filed 2022-05-31
2020-11-305.35K CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-01-14
5.35K CAD
10-Q · filed 2022-01-14
2020-08-310.00 CAD
10-Q · filed 2021-10-15